The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020
Open accessAbstract
Hepatitis C virus (HCV) infection is a major source of morbidity and mortality in the United States. HCV is transmitted primarily through parenteral exposures to infectious blood or body fluids that contain blood, most commonly through injection drug use. No vaccine against hepatitis C exists and no effective pre- or postexposure prophylaxis is available. More than half of persons who become infected with HCV will develop chronic infection. Direct-acting antiviral treatment can result in a virologic cure in most persons with 8-12 weeks of all-oral medication regimens. This report augments (i.e., updates and summarizes) previously published recommendations from CDC regarding testing for HCV infection in the United States (Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rec 2012;61[No. RR-4]). CDC is augmenting previous guidance with two new recommendations: 1) hepatitis C screening at least once in a lifetime for all adults aged ≥18 years, except in settings where the prevalence of HCV infection is <0.1% and 2) hepatitis C screening for all pregnant women during each pregnancy, except in settings where the prevalence of HCV infection is <0.1%. The recommendation for HCV testing that remains unchanged is regardless of age or setting prevalence, all persons with risk factors should be tested for hepatitis C, with periodic testing while risk factors persist. Any person who requests hepatitis C testing should receive it, regardless of disclosure of risk, because many persons might be reluctant to disclose stigmatizing risks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1998) · PsycEXTRA Dataset · doi:10.1037/e547602006-001 · Cited by 1,213
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Natural history of hepatitis C.
Westbrook, R. H., & Dusheiko, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.012 · Cited by 1,049
Smith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y. T., Holtzman, D. J., Teo, C., Jewett, A., Baack, B. N., Rein, D. B., Patel, N., et al. (2012) · PubMed · Cited by 991
Hepatitis C: the clinical spectrum of disease.
Hoofnagle, J. H. (1997) · Hepatology · doi:10.1002/hep.510260703 · Cited by 765 · cited 1×
“Persons with acute HCV infection are typically either asymptomatic or have a mild clinical illness like that of other types of viral hepatitis (24).”
BackgroundMohaghegh, H. (2014) · Journal of Liver · doi:10.4172/2167-0889.1000147 · Cited by 609
Zibbell, J. E., Iqbal, K., Patel, R. C., Suryaprasad, A. G., Sanders, K. J., Moore-Moravian, L., Serrecchia, J., Blankenship, S., Ward, J. W., & Holtzman, D. J. (2015) · PubMed Central · Cited by 507
Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016
Hofmeister, M. G., Rosenthal, E. M., Barker, L. K., Rosenberg, E. S., Barranco, M. A., Hall, E. W., Edlin, B. R., Mermin, J., Ward, J. W., & Ryerson, A. B. (2019) · Hepatology · doi:10.1002/hep.30297 · Cited by 486
Self-citationVertical Transmission of Hepatitis C Virus: Systematic Review and Meta-analysis
Benova, L., Mohamoud, Y. A., Calvert, C., & Abu-Raddad, L. J. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu447 · Cited by 479
Moyer, V. A. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-5-201309030-00672 · Cited by 475
Toward a more accurate estimate of the prevalence of hepatitis C in the United States
Edlin, B. R., Eckhardt, B. J., Shu, M. A., Holmberg, S. D., & Swan, T. (2015) · Hepatology · doi:10.1002/hep.27978 · Cited by 433
Natural History of Hepatitis C
Thomas, D. L., & Seeff, L. B. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2005.05.003 · Cited by 402
(1997) · PsycEXTRA Dataset · doi:10.1037/e547472006-001 · Cited by 305
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.1123 · Cited by 305
Maheshwari, A., Ray, S., & Thuluvath, P. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61116-2 · Cited by 295
Hepatitis C: the clinical spectrum of the disease
Marcellin, P. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80368-7 · Cited by 257
Natural History of Hepatitis C
Lingala, S., & Ghany, M. G. (2015) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.07.003 · Cited by 252
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.22980 · Cited by 212
Three Broad Modalities in the Natural History of Vertically Acquired Hepatitis C Virus Infection
The European Paediatric Hepatitis C Virus Network (2005) · Clinical Infectious Diseases · doi:10.1086/430601 · Cited by 193
Epidemiology and natural history of hepatitis C virus infection.
Lee, M., Yang, H., Yuan, Y., L'Italien, G. J., & Chen, C. (2014) · PubMed · doi:10.3748/wjg.v20.i28.9270 · Cited by 186
Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016
Rosenberg, E. S., Rosenthal, E. M., Hall, E. W., Barker, L., Hofmeister, M. G., Sullivan, P. S., Dietz, P., Mermin, J., & Ryerson, A. B. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.6371 · Cited by 175
Self-citationPrevention of Hepatitis C by Screening and Treatment in U.S. Prisons
He, T., Li, K., Roberts, M. S., Spaulding, A. C., Ayer, T., Grefenstette, J. J., & Chhatwal, J. (2016) · Annals of Internal Medicine · doi:10.7326/m15-0617 · Cited by 167
Hepatitis C in pregnancy: screening, treatment, and management
Hughes, B. L., Page, C. M., & Kuller, J. A. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.07.039 · Cited by 165
Sexually acquired hepatitis C virus infection: a review
Chan, D. P. C., Sun, H., Wong, H. T. H., Lee, S. S., & Hung, C. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.05.030 · Cited by 161
A practical approach to calculate sample size for herd prevalence surveys
Humphry, R. W., Cameron, A. R., & Gunn, G. J. (2004) · Preventive Veterinary Medicine · doi:10.1016/j.prevetmed.2004.07.003 · Cited by 151
Hepatitis C Seroprevalence among Prison Inmates since 2001: Still High but Declining
Varan, A. K., Mercer, D. W., Stein, M. S., & Spaulding, A. C. (2014) · Public Health Reports · doi:10.1177/003335491412900213 · Cited by 122
Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States
Eckman, M. H., Talal, A. H., Gordon, S. C., Schiff, E. R., & Sherman, K. E. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit069 · Cited by 122
Hepatitis C virus infection among women giving birth—Tennessee and United States, 2009–2014.
Patrick, S. W., Bauer, A. M., Warren, M. D., Jones, T. F., & Wester, C. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6618a3 · Cited by 113
Self-citationKim, H.-S., Yang, J. D., El‐Serag, H. B., & Kanwal, F. (2019) · Journal of Viral Hepatitis · doi:10.1111/jvh.13060 · Cited by 108
Cost-effectiveness and Population Outcomes of General Population Screening for Hepatitis C
Coffin, P. O., Scott, J. D., Golden, M. R., & Sullivan, S. D. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis011 · Cited by 104
Vertical transmission of hepatitis C virus: Current knowledge and perspectives
Yeung, C., Lee, H.-C., Chan, W.-T., Jiang, C.-B., Chang, S.-W., & Chuang, C.-K. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i9.643 · Cited by 100
Skeer, M. R., Ladin, K., Wilkins, L. E., Landy, D. M., & Stopka, T. J. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.06.013 · Cited by 87
Estimating Acute Viral Hepatitis Infections From Nationally Reported Cases
Klevens, R. M., Liu, S. V., Roberts, H., Jiles, R. B., & Holmberg, S. D. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301601 · Cited by 83
Routine hepatitis C virus screening in pregnancy: A cost-effectiveness analysis
Plunkett, B. A., & Grobman, W. A. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.10.600 · Cited by 80
Assoumou, S. A., Tasillo, A., Leff, J. A., Schackman, B. R., Drainoni, M., Horsburgh, C. R., Barry, M. A., Regis, C., Kim, A. Y., Marshall, A. D., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix798 · Cited by 80
Cost-effectiveness of Universal Hepatitis C Virus Screening of Pregnant Women in the United States
Chaillon, A., Rand, E. B., Reau, N. S., & Martin, N. K. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz063 · Cited by 74
Barocas, J. A., Tasillo, A., Yazdi, G. E., Wang, J., Vellozzi, C. J., Hariri, S., Isenhour, C. J., Randall, L. M., Ward, J. W., Mermin, J., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy098 · Cited by 72
Wang, L. S., D'Souza, L. S., & Jacobson, I. M. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24554 · Cited by 57
Hepatitis C Virus in Women of Childbearing Age, Pregnant Women, and Children
Schillie, S. F., Canary, L., Koneru, A., Nelson, N. P., Tanico, W., Kaufman, H. W., Hariri, S., & Vellozzi, C. J. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.05.029 · Cited by 56
Self-citationUSPHS/IDSA Prevention of Opportunistic Infections Working Group (2000) · Clinical Infectious Diseases · doi:10.1086/313848 · Cited by 54
Krans, E. E., Zickmund, S. L., Rustgi, V. K., Park, S. Y., Dunn, S. L., & Schwarz, E. B. (2015) · Substance Abuse · doi:10.1080/08897077.2015.1118720 · Cited by 53
Tasillo, A., Yazdi, G. E., Nolen, S., Schillie, S. F., Vellozzi, C. J., Epstein, R. L., Randall, L. M., Salomon, J. A., & Linas, B. P. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003062 · Cited by 53
Self-citationJones, L., Atkinson, A. M., Bates, G., et al. (2013) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.11.004 · Cited by 47
Hepatitis C Virus universal screening versus risk based selective screening during pregnancy
Waruingi, W., Mhanna, M. J., Kumar, D., et al. (2016) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-15915024 · Cited by 42
de la Flor, C., Porsa, E., & Nijhawan, A. E. (2017) · Public Health Reports · doi:10.1177/0033354917732755 · Cited by 42
Younossi, Z. M., Blissett, D., Blissett, R. S., Henry, L. L., Younossi, Y., Beckerman, R., & Hunt, S. (2017) · Liver International · doi:10.1111/liv.13519 · Cited by 41
Perz, J. F., Grytdal, S., Beck, S., Fireteanu, A. M., Poissant, T. M., Rizzo, E., Bornschlegel, K., Thomas, A. R., Balter, S., Miller, J. T., et al. (2012) · Hepatology · doi:10.1002/hep.25688 · Cited by 40
Guh, A. Y., Thompson, N. D., Schaefer, M. K., Patel, P. R., & Perz, J. F. (2012) · Medical Care · doi:10.1097/mlr.0b013e31825517d4 · Cited by 38
Zou, B., Yeo, Y. H., Le, M. H., Henry, L. L., Chang, E. T., Lok, A. S.-F., Cheung, R. C., & Nguyen, M. H. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz479 · Cited by 37
Hepatitis C virus infection in children: How do we prevent it and how do we treat it?
Nwaohiri, A. N., Schillie, S. F., Bulterys, M., & Kourtis, A. P. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1509707 · Cited by 32
Self-citationJones, C. R., Flower, B., Barber, E., Simmons, B., & Cooke, G. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15411.1 · Cited by 27
Deacon, R. M., Mooney‐Somers, J., Treloar, C., & Maher, L. (2013) · Health & Social Care in the Community · doi:10.1111/hsc.12026 · Cited by 25
Is there a case for hepatitis C infection screening in the antenatal period?
Pembrey, L., Newell, M., & Peckham, C. S. (2003) · Journal of Medical Screening · doi:10.1258/096914103771773230 · Cited by 22
“Seek, test, treat and retain” for hepatitis C in the United States criminal justice system
Larney, S., Beckwith, C. G., Zaller, N. D., Montague, B. T., & Rich, J. D. (2014) · International Journal of Prisoner Health · doi:10.1108/ijph-11-2013-0051 · Cited by 20
Ly, W., Cocohoba, J. M., Chyorny, A., Halpern, J., Auerswald, C. L., & Myers, J. J. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001664 · Cited by 17
Brener, L., Ellard, J., Murphy, D., & Callander, D. (2013) · Sexual Health · doi:10.1071/sh12179 · Cited by 16
Gowda, C., Kennedy, S., Glover, C., Prasad, M. R., Wang, L., & Honegger, J. R. (2018) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12481 · Cited by 15
Brener, L., Murphy, D., Cama, E. J., & Ellard, J. (2015) · Sexual Health · doi:10.1071/sh14239 · Cited by 15
Antenatal screening for hepatitis C: Universal or risk factor based?
Wilson, E., & Beckmann, M. M. (2015) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12296 · Cited by 14
Test4HepC: Promoting Hepatitis C Testing to Baby Boomers Using Social Media
Plant, A., Snow, E. G., Montoya, J. A., Young, S. D., Javanbakht, M., & Klausner, J. D. (2019) · Health Promotion Practice · doi:10.1177/1524839919833987 · Cited by 11
Terrault, N. A., Monto, A., Stinchon, M. R., Rusie, E., & Moreo, K. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.9.s1 · Cited by 9
Reynolds, G. L., Fisher, D. G., Brocato, J., Otterloo, L. R. V., Khahlil, K., & Huckabay, L. M. D. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462416684460 · Cited by 8
Turner, B. J., Craig, K., Makanji, V. S., Flores, B. E., & Hernández, L. (2017) · Journal of Clinical Nursing · doi:10.1111/jocn.13806 · Cited by 8
Collier, M. G., Holtzman, D. J., & Holmberg, S. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00220-6 · Cited by 4
Cited by
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Bhattacharya, D., Aronsohn, A., Price, J., Lo Re, V., the American Association for the Study of Liver Diseases–Infectious Diseases Society of America HCV Guidance Panel, Heald, J., Demisashi, G., Durzy, E., Davis-Owino, A., & Tynes, S. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad319 · Cited by 296
Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023
Conners, E. E., Panagiotakopoulos, L., Hofmeister, M. G., Spradling, P. R., Hagan, L. M., Harris, A. M., Rogers-Brown, J. S., Wester, C., Nelson, N. P., Contributors, et al. (2023) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7201a1 · Cited by 268
Self-citationUS Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.22980 · Cited by 212
Metadata
- Authors
- Schillie, S., Wester, C., Osborne, M., Wesolowski, L., & Ryerson, A. B.
- Venue
- MMWR. Recommendations and Reports
- Published
- 2020-04-10
- Volume
- 69
- Issue
- 2
- Pages
- 1-17
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- OpenAlex
- W3015631374
- Cited by
- 558
- References
- 67
- FWCI
- 42.70
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.